オハイオにおけるアルツハイマー病の臨床試験
オハイオ内の拠点で、アルツハイマー病に関する17件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Dayton
- Clinical Site, Independence
被験者募集中第2相
55歳〜90歳 · 全性別 · 2026/09/30更新 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2617, Blue Ash
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/28更新 · NCT06937229A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Local Institution - 1265, Cleveland
- Ohio State University, Columbus
- Local Institution - 1258, Dayton
- 他1件
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/22更新 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- NDx Clinical Research, Dayton
被験者募集中第2相
55歳〜80歳 · 全性別 · 2026/09/21更新 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Ohio State University, Columbus
被験者募集中第3相
50歳〜90歳 · 全性別 · 2026/09/21更新 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Velocity Clinical Research - Blue Ash, Blue Ash
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/16更新 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Cleveland Clinic, Cleveland
- Local Institution - 0087, Columbus
被験者募集中第2相
55歳〜90歳 · 全性別 · 2026/09/01更新 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Insight Clinical Trials ( Site 1011), Independence
- Neuro-Behavioral Clinical Research ( Site 1028), North Canton
被験者募集中第2相
50歳〜85歳 · 全性別 · 2026/08/26更新 · NCT07033494A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Ohio State University, Columbus
- NDx Clinical Research Inc., Dayton
被験者募集中第3相
60歳〜85歳 · 全性別 · 2026/08/20更新 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Cleveland Clinic, Cleveland
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/04更新 · NCT06563895A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- NDx Clinical Research, Inc., Dayton
- Care Access - Lima, Lima
被験者募集中第3相
55歳以上 · 全性別 · 2026/07/07更新 · NCT07602582A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Local Institution - 0029, Cleveland
- Insight Clinical Trials LLC - Independence, Independence
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/06/30更新 · NCT06947941A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- The Ohio State University, Columbus
被験者募集中第2相
50歳〜85歳 · 全性別 · 2026/06/26更新 · NCT07094516[18F]PI-2620 Phase 3 Histopathological Study
- Insight Clinical Trials LLC, Beachwood
- Valley Medical Research, Centerville
被験者募集中第3相
50歳以上 · 全性別 · 2026/05/22更新 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Case Western Reserve University, Beachwood
- University of Cincinnati, Cincinnati
被験者募集中観察研究
25歳〜55歳 · 全性別 · 2026/05/18更新 · NCT04165109Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
- Ohio University, Athens
- The Ohio State University, Columbus
被験者募集中
60歳以上 · 全性別 · 2026/03/05更新 · NCT05748613Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- The Ohio State University, Columbus
被験者募集中観察研究
18歳以上 · 全性別 · 2025/03/30更新 · NCT03019757ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。